PCSK9

Uncovering the Mechanism of Action of Evolocumab against PAD

Deciphering a drug’s MoA is crucial for making informed decisions in drug development, paving the way for the development of more targeted and effective therapeutic solutions. AI can revolutionize this process by facilitating knowledge discovery without bias, unveiling hidden drug-disease interactions.

Written by
Elizabeth Bolitho
  • Categories
  • Disease Pathophysiology
Receive the latest newsletter directly to your inbox

Mechanisms Matter in Drug Development

Identifying PAD Treatments in Clinical Trials

Biological Mediators of Evolocumab in PAD

Uncovering the Mechanism of Action of Evolocumab against PAD image 0
Figure 1: Genes and proteins which may mediate the effect of evolocumab against PAD.

Conclusion

References

More on Disease Pathophysiology